Literature DB >> 29018932

Analysis of Growth, Nutritional Status and Hospital Visitation Scores Associated with Reflux After Nissen Fundoplication in Neurologically Impaired Children with Gastroesophageal Reflux.

Chaeyoun Oh1, Joong Kee Youn1, Ji-Won Han1, Hyun-Young Kim2,3, Sung-Eun Jung1.   

Abstract

BACKGROUND: Neurologically impaired children (NIC) often experience swallowing difficulties and gastroesophageal reflux disease (GERD). Although these conditions could place children in a state of poor nutritional status and prevent them from thriving, there is insufficient research evaluating growth and nutritional status following fundoplication in these patients.
METHOD: This is a retrospective study of patients who were neurologically impaired and underwent Nissen fundoplication between April 2001 and March 2015. Seventy-six patients were enrolled, and the follow-up period was 12 months or longer. Growth was measured by the change in body weight and height. Nutritional status was measured by the change in body mass index, serum albumin and protein level.
RESULTS: Median age at operation was 1.85 years old, and median body weight was 10 kg. The respective Z scores for weight and height showed significant improvements after 1 year since the operation compared to 1 year within the operation (-2.42 ± 2.19 vs. -1.31 ± 1.96, P < 0.001) (-1.6 ± 2.16 vs. -1.05 ± 1.69, P = 0.002). The respective Z scores for body mass index, albumin and protein also showed improvements after 1 year since the operation compared to 1 year within the operation (-2.07 ± 2.99 vs. -0.89 ± 2.1, P < 0.001) (3.55 ± 0.48 vs. 3.86 ± 0.45, P < 0.001) (6.22 ± 0.76 vs. 6.65 ± 0.51, P < 0.001). Hospital visitation scores associated with reflux were significantly lower after the operation (4.1 ± 3.43 vs. 1.18 ± 1.67, P < 0.001).
CONCLUSIONS: In summary, after Nissen fundoplication in NIC with GER, growth and nutritional status improved significantly. Also, hospital visitation scores associated with reflux decreased after the operation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29018932     DOI: 10.1007/s00268-017-4276-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  Evaluation of Nissen fundoplication in neurologically impaired children.

Authors:  H Rice; J H Seashore; R J Touloukian
Journal:  J Pediatr Surg       Date:  1991-06       Impact factor: 2.545

Review 2.  Gastrointestinal problems in the handicapped child.

Authors:  S K Chong
Journal:  Curr Opin Pediatr       Date:  2001-10       Impact factor: 2.856

3.  Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey.

Authors:  S Reilly; D Skuse; X Poblete
Journal:  J Pediatr       Date:  1996-12       Impact factor: 4.406

4.  Long-term outcome of laparoscopic nissen fundoplication compared with laparoscopic thal fundoplication in children: a prospective, randomized study.

Authors:  Rainer Kubiak; James Andrews; Hugh W Grant
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

5.  Do antireflux operations decrease the rate of reflux-related hospitalizations in children?

Authors:  Adam B Goldin; Robert Sawin; Kristy D Seidel; David R Flum
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

6.  Nissen fundoplication in children with profound neurologic disability. High risks and unmet goals.

Authors:  C D Smith; H B Othersen; N J Gogan; J D Walker
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

7.  Laparoscopic Nissen fundoplication in childhood.

Authors:  T E Lobe; K P Schropp; K Lunsford
Journal:  J Pediatr Surg       Date:  1993-03       Impact factor: 2.545

8.  Laparoscopic Nissen fundoplication in infants and children: analysis of 106 consecutive patients with special emphasis in neurologically impaired vs. neurologically normal patients.

Authors:  Jan Mathei; Willy Coosemans; Philippe Nafteux; George Decker; Paul De Leyn; Dirk Van Raemdonck; Ilse Hoffman; Christiane Deboeck; Marijke Proesmans; Toni Lerut
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

9.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

10.  Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN).

Authors:  Yvan Vandenplas; Colin D Rudolph; Carlo Di Lorenzo; Eric Hassall; Gregory Liptak; Lynnette Mazur; Judith Sondheimer; Annamaria Staiano; Michael Thomson; Gigi Veereman-Wauters; Tobias G Wenzl
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-10       Impact factor: 2.839

View more
  4 in total

1.  Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms.

Authors:  Yuan He; Zhi-Jun Duan; Cheng-Fang Wang; Yu-Shan Wei; Ming-Xu Cai
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-20       Impact factor: 3.168

2.  Total esophagogastric dissociation (TEGD) in neurologically impaired children: the floor to parents.

Authors:  Sara Maria Cravano; Marco Di Mitri; Giovanni Parente; Eduje Thomas; Chiara Girella; Simone D'Antonio; Tommaso Gargano; Mario Lima
Journal:  Updates Surg       Date:  2022-09-21

3.  The outcomes of fundoplication and gastrostomy in neurologically impaired children in a tertiary care hospital in Saudi Arabia.

Authors:  Mohammed K AlNamshan; Nawaf M AlKharashi; Stanley J Crankson; Saud A AlJadaan; Nasir U Khawaja; Shahad A AlSaif
Journal:  Saudi Med J       Date:  2019-08       Impact factor: 1.484

Review 4.  Focus on gastroesophageal reflux disease in patients with cystic fibrosis.

Authors:  Annarita Bongiovanni; Sara Manti; Giuseppe Fabio Parisi; Maria Papale; Enza Mulè; Novella Rotolo; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2020-11-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.